4 April 2018

Martijn Simons received the ‘Radboudumc Masterprijs Biomedical Sciences 2016-2017’ for his master internship entitled ‘The influence of a risk-based follow-up on the early detection of recurrences in patients treated for oropharyngeal cancer’.

During his internship, Martijn explored possibilities to personalize the current follow-up schedule and reduce the number of follow-up consultations compared to the current consensus-based follow-up schedule. He was supervised by André Verbeek and Anne Aarts (theme Women's cancers) in collaboration with Robert Takes and Tim Govers (theme Rare cancers). 
We would like to congratulate Martijn and his supervisors with this price. Martijn will continue his master’s piece of work as a PhD student at Maastricht University, focussing on the expected value of personalized care in cost-effectiveness analyses .
 

Related news items


Mireille Broeders appointed member of the Dutch Health Council

16 November 2021

Mireille Broeders, professor of Personalized Cancer Screening, has been appointed as a member of the permanent Committee on Population Screening of the Dutch Health Council (Gezondheidsraad).

read more

Optimizing workup in head and neck cancer (HNC)

23 July 2020

In the journal Cancer RIHS researcher Henrieke Schutte described the outcomes after the implementation of a fast-track multidisciplinary integrated HNC care program: time-to-treatment was significantly reduced and survival and patient satisfaction increased significantly without increasing costs.

read more

Mireille Broeders appointed full Professor of Personalized Cancer Screening

18 June 2020

Mireille Broeders of the Department for Health Evidence has been appointed full professor of Personalized Cancer Screening. This appointment became effective on 1 May 2020.

read more

Guiding the surgeon real-time tumor visualization during surgery

26 February 2020

Incomplete excision of tumor tissue negatively affects the prognosis of the patient. RIHS researcher Mark Rijpkema and colleagues are working on the development of new dual-labeled tracers and currently are implementing this into the clinic.

read more

Awarded KWF grants for Radboudumc researchers

18 December 2019

KWF is investing 2.7 million euros in five different studies at Radboudumc. The awards are part of the new round of funding by DCS, in which over 34 million euros will be granted to Dutch cancer research. We congratulate our researchers with this funding and wish them success with their great work.

read more

Bart Kiemeney finishes 1st in the Tour and raises thousands of euros

30 July 2019

With over €47,000 on the counter, Kiemeney can see the Tour de France as a great success.

read more